Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.

F Colotta, S Saccani, JG Giri, SK Dower… - … (Baltimore, Md.: 1950 …, 1996 - journals.aai.org
Journal of Immunology (Baltimore, Md.: 1950), 1996journals.aai.org
The aim of this study was to investigate the expression and release of the IL-1 type II decoy
receptor (R) in mononuclear phagocytes, which play a central role in immune and chronic
inflammatory reactions. Human monocytes expressed both type I and type II R transcripts,
the latter being two-to threefold more represented. By cross-linking and Ab blocking, the
predominant surface IL-1-binding molecule was the decoy RII. IL-4, IL-13, and
dexamethasone induced RI and RII transcripts and augmented the number of IL-1-binding …
Abstract
The aim of this study was to investigate the expression and release of the IL-1 type II decoy receptor (R) in mononuclear phagocytes, which play a central role in immune and chronic inflammatory reactions. Human monocytes expressed both type I and type II R transcripts, the latter being two- to threefold more represented. By cross-linking and Ab blocking, the predominant surface IL-1-binding molecule was the decoy RII. IL-4, IL-13, and dexamethasone induced RI and RII transcripts and augmented the number of IL-1-binding sites with no modification of Kd values. The induced surface receptor was identified as the decoy RII. These stimuli induced the release of a soluble R with a m.w. of approximately 60 kDa, of which N-glycosylation contributed 22 kDa compared with 45 kDa released from polymorphonuclear leukocytes, of which N-glycosylation contributed 15 kDa. IL-13 and dexamethasone induced a release of 24 ng/ml/2 x 10(7) cells (from 8.7 to 43.2 ng/ml) and 25.6 ng/ml/2 x 10(7) cells (from 9.7 to 36.8 ng/ml) of decoy RII in 18 h, respectively (six donors). Thus, for instance, IL-13-treated (18 h) cells expressed 3.5 x 10(3) sites/cell and released 12 x 10(3) decoy RII/cell. The released decoy RII from monocytes bound IL-1apha and IL-1 receptor antagonist 30- and 2-fold less avidly than IL-1beta, respectively. In vitro-matured, monocyte-derived macrophages showed higher levels of surface expression and release of the IL-1 decoy RII. The results show that, on exposure to diverse molecules with anti-inflammatory properties, mononuclear phagocytes express and release copious amounts of a novel version of the soluble IL-1 decoy RII.
journals.aai.org